Circulating small RNA signatures differentiate accurately the subtypes of muscular dystrophies: small-RNA next-generation sequencing analytics and functional insights.


Journal

RNA biology
ISSN: 1555-8584
Titre abrégé: RNA Biol
Pays: United States
ID NLM: 101235328

Informations de publication

Date de publication:
2022
Historique:
entrez: 7 4 2022
pubmed: 8 4 2022
medline: 9 4 2022
Statut: ppublish

Résumé

Muscular dystrophies are a group of rare and severe inherited disorders mainly affecting the muscle tissue. Duchene Muscular Dystrophy, Myotonic Dystrophy types 1 and 2, Limb Girdle Muscular Dystrophy and Facioscapulohumeral Muscular Dystrophy are some of the members of this family of disorders. In addition to the current diagnostic tools, there is an increasing interest for the development of novel non-invasive biomarkers for the diagnosis and monitoring of these diseases. miRNAs are small RNA molecules characterized by high stability in blood thus making them ideal biomarker candidates for various diseases. In this study, we present the first genome-wide next-generation small RNA sequencing in serum samples of five different types of muscular dystrophy patients and healthy individuals. We identified many small RNAs including miRNAs, lncRNAs, tRNAs, snoRNAs and snRNAs, that differentially discriminate the muscular dystrophy patients from the healthy individuals. Further analysis of the identified miRNAs showed that some miRNAs can distinguish the muscular dystrophy patients from controls and other miRNAs are specific to the type of muscular dystrophy. Bioinformatics analysis of the target genes for the most significant miRNAs and the biological role of these genes revealed different pathways that the dysregulated miRNAs are involved in each type of muscular dystrophy investigated. In conclusion, this study shows unique signatures of small RNAs circulating in five types of muscular dystrophy patients and provides a useful resource for future studies for the development of miRNA biomarkers in muscular dystrophies and for their involvement in the pathogenesis of the disorders.

Identifiants

pubmed: 35388741
doi: 10.1080/15476286.2022.2058817
pmc: PMC8993092
doi:

Substances chimiques

Biomarkers 0
MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

507-518

Subventions

Organisme : CIHR
ID : FDN-167281
Pays : Canada

Références

PLoS One. 2013;8(2):e55281
pubmed: 23418438
Front Genet. 2019 Mar 11;10:169
pubmed: 30915102
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Sci Rep. 2016 Dec 01;6:38174
pubmed: 27905532
EMBO Mol Med. 2011 May;3(5):258-65
pubmed: 21425469
Mol Ther Nucleic Acids. 2014 Jul 22;3:e177
pubmed: 25050825
Mol Ther Nucleic Acids. 2018 Dec 7;13:1-15
pubmed: 30219269
Clin Proteomics. 2016 Apr 05;13:9
pubmed: 27051355
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Neurology. 2003 Feb 25;60(4):657-64
pubmed: 12601109
Trends Mol Med. 2017 Nov;23(11):989-1001
pubmed: 28988850
Dev Med Child Neurol. 2019 Aug;61(8):964-971
pubmed: 30663041
Front Biosci (Landmark Ed). 2015 Jan 01;20(1):37-77
pubmed: 25553440
Lancet. 1989 Nov 25;2(8674):1269
pubmed: 2573772
Bioinformatics. 2009 Apr 15;25(8):1091-3
pubmed: 19237447
PLoS One. 2015 Apr 27;10(4):e0125341
pubmed: 25915631
Brain Res Bull. 2001 Oct-Nov 1;56(3-4):389-95
pubmed: 11719277
J Assist Reprod Genet. 2010 Jul;27(7):397-407
pubmed: 20490649
Bull Med Libr Assoc. 2000 Jul;88(3):265-6
pubmed: 10928714
Lancet. 2002 Feb 23;359(9307):687-95
pubmed: 11879882
PLoS One. 2008 Sep 05;3(9):e3148
pubmed: 18773077
Genome Biol. 2009;10(3):R25
pubmed: 19261174
Dis Model Mech. 2017 Apr 1;10(4):487-497
pubmed: 28188264
Environ Health Prev Med. 2014 Nov;19(6):452-8
pubmed: 25150707
Urol Oncol. 2010 Nov-Dec;28(6):655-61
pubmed: 19375957
J Dev Behav Pediatr. 2006 Dec;27(6):470-6
pubmed: 17164619
Front Cell Neurosci. 2017 Apr 20;11:101
pubmed: 28473756
Neurol Clin. 2014 Aug;32(3):729-49, ix
pubmed: 25037088
Neurology. 2010 Oct 26;75(17):1548-54
pubmed: 20975055
Int J Mol Sci. 2016 Aug 13;17(8):
pubmed: 27529242
Bioinformatics. 2013 Mar 1;29(5):661-3
pubmed: 23325622
Int J Mol Sci. 2019 Sep 13;20(18):
pubmed: 31540302
Dev Cell. 2012 Jan 17;22(1):38-51
pubmed: 22209328
J Mol Neurosci. 2018 Dec;66(4):617-628
pubmed: 30415446
Continuum (Minneap Minn). 2019 Dec;25(6):1662-1681
pubmed: 31794465
Sci Rep. 2018 Apr 4;8(1):5609
pubmed: 29618798
Eur J Epidemiol. 2011 Apr;26(4):261-4
pubmed: 21431839
Bioinformatics. 2014 Aug 1;30(15):2239-41
pubmed: 24713438
J Neurochem. 2014 Jun;129(5):877-83
pubmed: 24460924
Nature. 1992 Feb 6;355(6360):548-51
pubmed: 1346925
Hum Mol Genet. 2017 Sep 1;26(17):3285-3302
pubmed: 28637233
BMC Dev Biol. 2011 Jun 07;11:34
pubmed: 21645416
Neuromuscul Disord. 2014 Jun;24(6):509-15
pubmed: 24679513
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4402-7
pubmed: 19246379
Int J Mol Sci. 2019 Sep 19;20(18):
pubmed: 31546754
Neurol India. 2017 May-Jun;65(3):512-517
pubmed: 28488611
Skelet Muscle. 2014 Jun 10;4:12
pubmed: 24940479
Brain. 2002 Jan;125(Pt 1):4-13
pubmed: 11834588
Cell. 1987 Dec 24;51(6):919-28
pubmed: 3319190
PLoS One. 2011 Mar 30;6(3):e18388
pubmed: 21479190
Genome Biol. 2010;11(3):R25
pubmed: 20196867
Hum Mol Genet. 2016 Sep 15;25(18):3960-3974
pubmed: 27466195
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Cell. 2008 Dec 26;135(7):1189-200
pubmed: 19109891
Ther Adv Neurol Disord. 2020 Dec 25;13:1756286420979954
pubmed: 33488772
Arch Dis Child. 1980 Aug;55(8):589-94
pubmed: 7436514
Am J Hum Genet. 1992 Aug;51(2):396-403
pubmed: 1642237
Neuromuscul Disord. 2013 May;23(5):427-31
pubmed: 23466272
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Methods Mol Biol. 2018;1740:1-15
pubmed: 29388131
Mol Ther Nucleic Acids. 2012 Aug 14;1:e39
pubmed: 23344181
Proc Natl Acad Sci U S A. 2020 Nov 24;117(47):29691-29701
pubmed: 33148801
Mol Ther Methods Clin Dev. 2020 May 22;18:230-239
pubmed: 32637452
Nat Protoc. 2019 Mar;14(3):703-721
pubmed: 30804569
Muscle Nerve. 2008 Nov;38(5):1523-1524
pubmed: 18816620
Am J Pathol. 2014 Nov;184(11):2885-98
pubmed: 25194663
Phys Ther. 2005 Dec;85(12):1372-88
pubmed: 16305275
Hum Mol Genet. 2019 Oct 1;28(19):3199-3210
pubmed: 31211843
Curr Opin Neurol. 2016 Oct;29(5):635-41
pubmed: 27490667
J Cell Sci. 2015 Oct 1;128(19):3631-45
pubmed: 26272918
Continuum (Minneap Minn). 2016 Dec;22(6, Muscle and Neuromuscular Junction Disorders):1954-1977
pubmed: 27922502
Lancet. 2013 Mar 9;381(9869):845-60
pubmed: 23465426
Nucleic Acids Res. 2013 Nov;41(20):9500-13
pubmed: 23945935
Genes (Basel). 2020 Mar 19;11(3):
pubmed: 32204553
Genome Res. 2017 Mar;27(3):491-499
pubmed: 28100584
Front Neurosci. 2018 Sep 05;12:625
pubmed: 30233304
Stat Appl Genet Mol Biol. 2012 Oct 22;11(5):
pubmed: 23104842
Neurology. 2015 Jul 28;85(4):357-64
pubmed: 26215877
Cell Physiol Biochem. 2016;39(6):2381-2397
pubmed: 27832652
Hum Mol Genet. 2020 Sep 29;29(16):2746-2760
pubmed: 32744322
Muscle Nerve. 2005 Jul;32(1):1-18
pubmed: 15770660
Nucleic Acids Res. 2019 Jan 8;47(D1):D419-D426
pubmed: 30407594
Database (Oxford). 2016 Jul 03;2016:
pubmed: 27374120
Neurology. 2003 Jun 10;60(11):1854-7
pubmed: 12796551
Annu Rev Genomics Hum Genet. 2015;16:281-308
pubmed: 26048046
Genomics. 1991 Apr;9(4):570-5
pubmed: 2037288
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D140-4
pubmed: 16381832
Neurosci Biobehav Rev. 2013 Sep;37(8):1724-37
pubmed: 23850593
PLoS One. 2013 Nov 25;8(11):e80263
pubmed: 24282529
Cancer Res. 2010 Dec 1;70(23):9798-807
pubmed: 21098710

Auteurs

Andrea C Kakouri (AC)

Department of Bioinformatics, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

Demetris Koutalianos (D)

Department of Molecular Genetics, Function & Therapy, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

Andrie Koutsoulidou (A)

Department of Molecular Genetics, Function & Therapy, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

Anastasis Oulas (A)

Department of Bioinformatics, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

Marios Tomazou (M)

Department of Bioinformatics, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Department of Neurogenetics, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

Nikoletta Nikolenko (N)

National Hospital for Neurology and Neurosurgery, Queen Square, University College London Hospitals NHS Foundation Trust, London, UK.

Chris Turner (C)

National Hospital for Neurology and Neurosurgery, Queen Square, University College London Hospitals NHS Foundation Trust, London, UK.

Andreas Roos (A)

Department of Neuropediatrics, University Hospital Essen, Duisburg-Essen University, Germany.
Division of Neurology, Department of Medicine, Childrens Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, Canada.

Anna Lusakowska (A)

Department of Neurology, Medical University of Warsaw, Warsaw, Poland.

Katarzyna Janiszewska (K)

Department of Neurology, Central Hospital of Medical University of Warsaw, Poland.

George K Papadimas (GK)

Department of Neurology, Eginitio hospital, Medical School of Athens, Athens, Greece.

Constantinos Papadopoulos (C)

Department of Neurology, Eginitio hospital, Medical School of Athens, Athens, Greece.

Evangelia Kararizou (E)

Department of Neurology, Eginitio hospital, Medical School of Athens, Athens, Greece.

Eleni Zamba Papanicolaou (EZ)

Neuroepidemiology Department, Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.

Grainne Gorman (G)

Wellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, University of Newcastle, Newcastle, UK.

Hanns Lochmüller (H)

Division of Neurology, Department of Medicine, Childrens Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, Canada.
Division of Neurology, Department of Medicine, The Ottawa Hospital, Ottawa, ON, Canada.
Centro Nacional de AnálisisGenómico, Center for Genomic Regulation (CNAG-CRG), Barcelona Institute of Science and Technology (Bist), Barcelona, Spain.

George M Spyrou (GM)

Department of Bioinformatics, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

Leonidas A Phylactou (LA)

Department of Molecular Genetics, Function & Therapy, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH